Product NDC: | 0472-0013 |
Proprietary Name: | Griseofulviin (microsize) |
Non Proprietary Name: | Griseofulvin (microsize) |
Active Ingredient(s): | 125 mg/5mL & nbsp; Griseofulvin (microsize) |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0472-0013 |
Labeler Name: | Actavis Mid Atlantic LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065394 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070726 |
Package NDC: | 0472-0013-04 |
Package Description: | 120 mL in 1 BOTTLE (0472-0013-04) |
NDC Code | 0472-0013-04 |
Proprietary Name | Griseofulviin (microsize) |
Package Description | 120 mL in 1 BOTTLE (0472-0013-04) |
Product NDC | 0472-0013 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Griseofulvin (microsize) |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20070726 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Mid Atlantic LLC |
Substance Name | GRISEOFULVIN |
Strength Number | 125 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |